| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Laboratory Medicine, Kyoto University School of Medicine (S.K., A.M.), Kyoto 606-8507; the Department of Pathology, Kitasato University School of Medicine (Y.S., T.K.), Sagamihara, Kanagawa 228-0829; Ohyama Clinic (Y.O.), Sagamihara, Kanagawa 228-0802; the Department of Pediatrics, Hokkaido University School of Medicine (K.F.), Sapporo 060-0814; the Department of Pediatrics, Teikyo University Ichihara Hospital (H.I.), Ichihara, Chiba 299-0111; the Department of Medicine, Tokyo Womens Medical College (O.I.), Tokyo 162-0054, Japan; and the Department of Physiology, Ohio State University (S.M.J.), Columbus, Ohio 43210
Address all correspondence and requests for reprints to: Shinji Kosugi, M.D., Ph.D., Department of Laboratory Medicine, Kyoto University School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan. E-mail: kosugi{at}kuhp.kyoto-u.ac.jp
A missense and loss of function mutation of the
Na+/I- symporter (NIS) gene, T354P
[Thr354
Pro (ACA
CCA)], was found in the homozygous
state in two unrelated Japanese patients with iodide transport defect.
In this study we have identified the homozygous T354P NIS germline
mutation in seven Japanese patients, including one previously reported,
from five unrelated families. No other nucleotide changes were found in
the coding regions and the exon-intron boundaries of the NIS gene in
these seven patients. These results suggest a common prevalence of the
T354P mutation in Japanese patients. Although these seven patients have
the identical NIS mutation, T354P, marked heterogeneity in clinical
pictures, especially concerning goiter and hypothyroidism, were noted
among them. Therefore, another factor(s), but not the nature of the NIS
mutation, may account for the clinical heterogeneity among patients
with the iodide transport defect. We have previously reported that the
NIS messenger ribonucleic acid was markedly increased in the thyroid of
a patient with the homozygous T354P mutation. In this study we
demonstrated that the NIS proteins in the patients thyroids were
significantly increased (
10-fold) by Western blot analysis of
integral membrane proteins using an antibody against the C-terminal
peptide of the human NIS. Furthermore, we showed by immunohistochemical
staining that the T354P mutant NIS proteins were overexpressed in the
basal and lateral plasma membranes of patients thyrocytes.
This article has been cited by other articles:
![]() |
M. D. Reed-Tsur, A. De la Vieja, C. S. Ginter, and N. Carrasco Molecular Characterization of V59E NIS, a Na+/I- Symporter Mutant that Causes Congenital I- Transport Defect Endocrinology, June 1, 2008; 149(6): 3077 - 3084. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Szinnai, S. Kosugi, C. Derrien, N. Lucidarme, V. David, P. Czernichow, and M. Polak Extending the Clinical Heterogeneity of Iodide Transport Defect (ITD): A Novel Mutation R124H of the Sodium/Iodide Symporter Gene and Review of Genotype-Phenotype Correlations in ITD J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1199 - 1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. De la Vieja, C. S. Ginter, and N. Carrasco Molecular Analysis of a Congenital Iodide Transport Defect: G543E Impairs Maturation and Trafficking of the Na+/I- Symporter Mol. Endocrinol., November 1, 2005; 19(11): 2847 - 2858. [Abstract] [Full Text] [PDF] |
||||
![]() |
S M Park and V K K Chatterjee Genetics of congenital hypothyroidism J. Med. Genet., May 1, 2005; 42(5): 379 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. De la Vieja, C. S. Ginter, and N. Carrasco The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number J. Cell Sci., February 15, 2004; 117(5): 677 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Dohan, A. De la Vieja, V. Paroder, C. Riedel, M. Artani, M. Reed, C. S. Ginter, and N. Carrasco The Sodium/Iodide Symporter (NIS): Characterization, Regulation, and Medical Significance Endocr. Rev., February 1, 2003; 24(1): 48 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kosugi, H. Okamoto, A. Tamada, and F. Sanchez-Franco A Novel Peculiar Mutation in the Sodium/Iodide Symporter Gene in Spanish Siblings with Iodide Transport Defect J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3830 - 3836. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pohlenz, L. Duprez, R. E. Weiss, G. Vassart, S. Refetoff, and S. Costagliola Failure of Membrane Targeting Causes the Functional Defect of Two Mutant Sodium Iodide Symporters J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2366 - 2369. [Abstract] [Full Text] |
||||
![]() |
A. De la Vieja, O. Dohan, O. Levy, and N. Carrasco Molecular Analysis of the Sodium/Iodide Symporter: Impact on Thyroid and Extrathyroid Pathophysiology Physiol Rev, July 1, 2000; 80(3): 1083 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kosugi, S. Bhayana, and H. J. Dean A Novel Mutation in the Sodium/Iodide Symporter Gene in the Largest Family with Iodide Transport Defect J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3248 - 3253. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |